Evaluation of Vitamin B6 (pyridoxine) Effect on symptoms and quality of life in patients with irritable bowel syndrome (IBS)
Phase 2
- Conditions
- Irritable bowel syndrome.Irritable bowel syndrome
- Registration Number
- IRCT20211226053534N2
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Newly diagnosed patients with Irritable Bowel Syndrome (IBS) according to the Rome IV criteria
Age from 18 to 65 years old
Exclusion Criteria
Personal History of malignant diseases of the gastrointestinal tract, Celiac disease, Lactose intolerance, Diverticulitis, Gastrointestinal infection, Hypothyroidism and hyperthyroidism
Presence of other diseases during colonoscopy in individuals over 50 years of age
Pregnancy and lactation
Allergy to the study drug
Lack of consent to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Irritable bowel syndrome severity. Timepoint: At beginning of the study and four weeks after initiation of the study. Method of measurement: The irritable bowel severity scoring system (IBSSS).
- Secondary Outcome Measures
Name Time Method Quality of life in patients with irritable bowel syndrome. Timepoint: At beginning of the study and four weeks after initiation of the study. Method of measurement: Irritable bowel syndrome quality of life questionnaire (IBS-QOL).